Effects of the W153L substitution in HIV reverse transcriptase on viral replication and drug resistance to multiple categories of reverse transcriptase inhibitors.

MLA

Xu, Hong-Tao, et al. “Effects of the W153L Substitution in HIV Reverse Transcriptase on Viral Replication and Drug Resistance to Multiple Categories of Reverse Transcriptase Inhibitors.” Antimicrobial Agents and Chemotherapy, vol. 58, no. 8, Aug. 2014, pp. 4515–26. EBSCOhost, https://doi.org/10.1128/AAC.02729-14.

APA

Xu, H.-T., Colby-Germinario, S. P., Oliveira, M., Rajotte, D., Bethell, R., & Wainberg, M. A. (2014). Effects of the W153L substitution in HIV reverse transcriptase on viral replication and drug resistance to multiple categories of reverse transcriptase inhibitors. Antimicrobial Agents and Chemotherapy, 58(8), 4515–4526. https://doi.org/10.1128/AAC.02729-14

Chicago

Xu, Hong-Tao, Susan P Colby-Germinario, Maureen Oliveira, Daniel Rajotte, Richard Bethell, and Mark A Wainberg. 2014. “Effects of the W153L Substitution in HIV Reverse Transcriptase on Viral Replication and Drug Resistance to Multiple Categories of Reverse Transcriptase Inhibitors.” Antimicrobial Agents and Chemotherapy 58 (8): 4515–26. doi:10.1128/AAC.02729-14.